{"name": "BioPro Pharmaceutical",
 "permalink": "biopro-pharmaceutical",
 "crunchbase_url": "http://www.crunchbase.com/company/biopro-pharmaceutical",
 "homepage_url": "http://www.biopropharm.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "1-415-869-6764",
 "description": "",
 "created_at": "Mon Aug 30 13:28:20 UTC 2010",
 "updated_at": "Mon Aug 30 13:34:15 UTC 2010",
 "overview": "\u003Cp\u003EBioPro Pharmaceutical is an oncology specialty biopharmaceutical company that has infrastructure in the major countries of Asia, targeting pharmaceutical markets totaling US$30 billion. BioPro\u0026#8217;s expertise lies in its capability to market in-licensed pharmaceutical products in China and other Asian/Pacific countries. BioPro is unique in having regulatory expertise and marketing know-how applicable to all of Asia.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       53],
      "assets/images/resized/0009/9898/99898v1-max-150x150.jpg"],
     [[213,
       76],
      "assets/images/resized/0009/9898/99898v1-max-250x250.jpg"],
     [[213,
       76],
      "assets/images/resized/0009/9898/99898v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$5M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://www.biopropharm.com/modules.php?op=modload\u0026name=News\u0026file=article\u0026sid=28\u0026mode=thread\u0026order=0\u0026thold=0",
    "source_description": "BioPro Pharmaceutical Closes $5 Million Series A Equity Financing",
    "raised_amount": 5000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2005,
    "funded_month": 10,
    "funded_day": 18,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Sanders Morris Harris Group",
         "permalink": "sanders-morris-harris-group",
         "image":
          {"available_sizes":
            [[[150,
               25],
              "assets/images/resized/0009/9903/99903v1-max-150x150.jpg"],
             [[250,
               42],
              "assets/images/resized/0009/9903/99903v1-max-250x250.jpg"],
             [[361,
               62],
              "assets/images/resized/0009/9903/99903v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Two Transamerica Center",
    "address2": "505 Sansome Street, Suite 1200",
    "zip_code": "94111",
    "city": "San Francisco",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        76],
       "assets/images/resized/0009/9899/99899v1-max-150x150.jpg"],
      [[250,
        127],
       "assets/images/resized/0009/9899/99899v1-max-250x250.jpg"],
      [[450,
        229],
       "assets/images/resized/0009/9899/99899v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}